Cat. No.: DIA-0231006
Product Information | |
---|---|
CAS No. | 149904-87-0 |
Synonyms | CP 86325 Sodium |
Formula | C23H19N2NaO4S |
Molecular Weight | 442.46 |
Product Description | Darglitazone Sodium, a thiazolidinedione, is an orally active, potent, and selective PPAR-γ (peroxisome proliferator-activated receptor) agonist. Darglitazone Sodium is effective in controlling blood glucose and lipid metabolism, and can be used for type II diabetes research. |
Format & Storage | |
---|---|
Format | Solid |
Purity | > 97% |
Shipping | Shipped on dry ice. |
Storage | Protect from light. Powder: -80 °C, 2 years; -20 °C, 1 year. In solvent: -80 °C, 6 months; -20 °C, 1 month (protect from light). |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.